Viz LVO shows remarkable performance in the ALADIN Multicenter Trial presented at ESOC 2018

The ALADIN Multicenter Trial demonstrated remarkable performance of Viz LVO in its ability to accurately, consistently and rapidly detect large vessel occlusions (LVOs) retrospectively on 875 CTA images. Viz LVO detected anterior LVOs, extending from ICA-T to MCA-M1, with a sensitivity of 90% and a specificity of 86%. Hence, establishing Viz LVO as the most accurate LVO detection algorithm currently available in the United States. Further, Viz LVO detected the presence of an LVO and notified stroke specialists within 5 minutes of receiving the CTA images.